Clinical Trial Update: Spironolactone Improved Children With Gene Mutations Related to NCOR [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 clinical trial evaluating spironolactone in children with NCOR gene mutations, including autism spectrum disorder, reportedly showed impro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Spironolactone (spironolactone)

Snippet

Sponsor: Qilu Hospital of Shandong University | Conditions: NCOR Gene Mutations, Spironolactone | Phase 2, Phase 3 | Status: COMPLETED